Metformin and LW6 Impairs Pancreatic Cancer Cells and Reduces Nuclear Localization of YAP1

Overview

Journal J Cancer

Specialty Oncology

Date 2020 Jan 4

PMID 31897243

Citations 7

Authors

Xianbin Zhang

Peng Liu

Yuru Shang

Hagen Kerndl

Simone Kumstel

Peng Gong

Brigitte Vollmar

Dietmar Zechner

Affiliations

Soon will be listed here.

Abstract

The poor survival rate of pancreatic cancer is still a major challenge for the clinicians and their patients. In this study, we evaluated the efficacy of metformin, an inhibitor of oxidative phosphorylation, in combination with LW6, which impairs malate dehydrogenase 2 activities, in treating pancreatic cancer cells. We observed that this combinational therapy significantly reduced cell proliferation, migration, and significantly induced cell death when compared to cells treated by each monotherapy or Sham. In addition, we found that the combination of metformin and LW6 increased the phosphorylation of yes-associated protein 1 at serine 127 and attenuated the nuclear localization of this transcription factor. This combinatorial treatment also decreased the level of cellular yes-associated protein 1. This suggests that metformin in combination with LW6 impairs pancreatic cancer cells and reduces nuclear localization of yes-associated protein 1.

Citing Articles

Differentiation-Inducing Factor 1 Promotes Glucose Uptake via Direct Inhibition of Mitochondrial Malate Dehydrogenase in Mouse 3T3-L1 Cells.

Kubohara Y, Fukunaga Y, Shigenaga A, Kikuchi H Int J Mol Sci. 2024; 25(3).

PMID: 38339168 PMC: 10855897. DOI: 10.3390/ijms25031889.

HIF-1α Expression Increases Preoperative Concurrent Chemoradiotherapy Resistance in Hyperglycemic Rectal Cancer.

Huang Y, Chen Y, Huang C, Kuo S, Liao Y, Jhang W Cancers (Basel). 2022; 14(16).

PMID: 36011045 PMC: 9406860. DOI: 10.3390/cancers14164053.

Development of a Transcription Factor-Based Prognostic Model for Predicting the Immune Status and Outcome in Pancreatic Adenocarcinoma.

Zhang X, Li L, Liu P, Tian Y, Gong P J Immunol Res. 2022; 2022:4946020.

PMID: 35571561 PMC: 9098328. DOI: 10.1155/2022/4946020.

Novel sequential therapy with metformin enhances the effects of cisplatin in testicular germ cell tumours via YAP1 signalling.

He K, Li Z, Ye K, Zhou Y, Yan M, Qi H Cancer Cell Int. 2022; 22(1):113.

PMID: 35264157 PMC: 8905836. DOI: 10.1186/s12935-022-02534-w.

Role of Yes-associated Protein-1 in Gastrointestinal Cancers and Hepatocellular Carcinoma.

Qian X, Zhang W, Yang H, Zhang L, Kang N, Lai J Explor Res Hypothesis Med. 2021; 6(3):110-117.

PMID: 34589656 PMC: 8478289. DOI: 10.14218/ERHM.2021.00017.

References

Herrera-Martinez A, Pedraza-Arevalo S, L-Lopez F, Gahete M, Galvez-Moreno M, Castano J . Type 2 Diabetes in Neuroendocrine Tumors: Are Biguanides and Statins Part of the Solution?. J Clin Endocrinol Metab. 2018; 104(1):57-73. DOI: 10.1210/jc.2018-01455. View

Yu F, Zhao B, Panupinthu N, Jewell J, Lian I, Wang L . Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling. Cell. 2012; 150(4):780-91. PMC: 3433174. DOI: 10.1016/j.cell.2012.06.037. View

Gui D, Sullivan L, Luengo A, Hosios A, Bush L, Gitego N . Environment Dictates Dependence on Mitochondrial Complex I for NAD+ and Aspartate Production and Determines Cancer Cell Sensitivity to Metformin. Cell Metab. 2016; 24(5):716-727. PMC: 5102768. DOI: 10.1016/j.cmet.2016.09.006. View

Naik R, Ban H, Jang K, Kim I, Xu X, Harmalkar D . Methyl 3-(3-(4-(2,4,4-Trimethylpentan-2-yl)phenoxy)-propanamido)benzoate as a Novel and Dual Malate Dehydrogenase (MDH) 1/2 Inhibitor Targeting Cancer Metabolism. J Med Chem. 2017; 60(20):8631-8646. DOI: 10.1021/acs.jmedchem.7b01231. View

Zhao B, Li L, Lei Q, Guan K . The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version. Genes Dev. 2010; 24(9):862-74. PMC: 2861185. DOI: 10.1101/gad.1909210. View

Kim B, Lee K, Jung H, Bhattarai D, Kwon H . HIF-1α suppressing small molecule, LW6, inhibits cancer cell growth by binding to calcineurin b homologous protein 1. Biochem Biophys Res Commun. 2015; 458(1):14-20. DOI: 10.1016/j.bbrc.2015.01.031. View

Mo J, Meng Z, Kim Y, Park H, Hansen C, Kim S . Cellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathway. Nat Cell Biol. 2015; 17(4):500-10. PMC: 4380774. DOI: 10.1038/ncb3111. View

Lau A, Curtis S, Fillmore C, Rowbotham S, Mohseni M, Wagner D . Tumor-propagating cells and Yap/Taz activity contribute to lung tumor progression and metastasis. EMBO J. 2014; 33(5):468-81. PMC: 3989628. DOI: 10.1002/embj.201386082. View

Eleftheriadis T, Pissas G, Mavropoulos A, Liakopoulos V, Stefanidis I . Comparison of the effect of the aerobic glycolysis inhibitor dichloroacetate and of the Krebs cycle inhibitor LW6 on cellular and humoral alloimmunity. Biomed Rep. 2017; 7(5):439-444. PMC: 5700391. DOI: 10.3892/br.2017.980. View

10.

Sato M, Hirose K, Kashiwakura I, Aoki M, Kawaguchi H, Hatayama Y . LW6, a hypoxia-inducible factor 1 inhibitor, selectively induces apoptosis in hypoxic cells through depolarization of mitochondria in A549 human lung cancer cells. Mol Med Rep. 2015; 12(3):3462-3468. PMC: 4526100. DOI: 10.3892/mmr.2015.3862. View

11.

Sivalingam V, McVey R, Gilmour K, Ali S, Roberts C, Renehan A . A presurgical window-of-opportunity study of metformin in obesity-driven endometrial cancer. Lancet. 2015; 385 Suppl 1:S90. DOI: 10.1016/S0140-6736(15)60405-6. View

12.

Oettle H, Post S, Neuhaus P, Gellert K, Langrehr J, Ridwelski K . Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA. 2007; 297(3):267-77. DOI: 10.1001/jama.297.3.267. View

13.

Chai X, Chu H, Yang X, Meng Y, Shi P, Gou S . Metformin Increases Sensitivity of Pancreatic Cancer Cells to Gemcitabine by Reducing CD133+ Cell Populations and Suppressing ERK/P70S6K Signaling. Sci Rep. 2015; 5:14404. PMC: 4585731. DOI: 10.1038/srep14404. View

14.

Yamashita M, Ogasawara M, Kawasaki Y, Niisato M, Saito H, Kasai S . Deficiency of protein-L-isoaspartate (D-aspartate) -methyl-transferase expression under endoplasmic reticulum stress promotes epithelial mesenchymal transition in lung adenocarcinoma. Oncotarget. 2018; 9(17):13287-13300. PMC: 5862578. DOI: 10.18632/oncotarget.24324. View

15.

Ben Sahra I, Laurent K, Loubat A, Giorgetti-Peraldi S, Colosetti P, Auberger P . The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level. Oncogene. 2008; 27(25):3576-86. DOI: 10.1038/sj.onc.1211024. View

16.

Salcedo Allende M, Zeron-Medina J, Hernandez J, Macarulla T, Balsells J, Merino X . Overexpression of Yes Associated Protein 1, an Independent Prognostic Marker in Patients With Pancreatic Ductal Adenocarcinoma, Correlated With Liver Metastasis and Poor Prognosis. Pancreas. 2017; 46(7):913-920. DOI: 10.1097/MPA.0000000000000867. View

17.

Zhang X, Abdelrahman A, Vollmar B, Zechner D . The Ambivalent Function of YAP in Apoptosis and Cancer. Int J Mol Sci. 2018; 19(12). PMC: 6321280. DOI: 10.3390/ijms19123770. View

18.

Siegel R, Miller K, Jemal A . Cancer statistics, 2018. CA Cancer J Clin. 2018; 68(1):7-30. DOI: 10.3322/caac.21442. View

19.

Amrutkar M, Gladhaug I . Pancreatic Cancer Chemoresistance to Gemcitabine. Cancers (Basel). 2017; 9(11). PMC: 5704175. DOI: 10.3390/cancers9110157. View

20.

Heallen T, Zhang M, Wang J, Bonilla-Claudio M, Klysik E, Johnson R . Hippo pathway inhibits Wnt signaling to restrain cardiomyocyte proliferation and heart size. Science. 2011; 332(6028):458-61. PMC: 3133743. DOI: 10.1126/science.1199010. View